Gender equity in academic rheumatology, current status and potential for improvement: a cross-sectional study to inform an EULAR task force.


Journal

RMD open
ISSN: 2056-5933
Titre abrégé: RMD Open
Pays: England
ID NLM: 101662038

Informations de publication

Date de publication:
08 2022
Historique:
received: 17 06 2022
accepted: 13 07 2022
entrez: 8 8 2022
pubmed: 9 8 2022
medline: 11 8 2022
Statut: ppublish

Résumé

Evidence on the current status of gender equity in academic rheumatology in Europe and potential for its improvement is limited. The EULAR convened a task force to obtain empirical evidence on the potential unmet need for support of female rheumatologists, health professionals and non-clinical scientists in academic rheumatology. This cross-sectional study comprised three web-based surveys conducted in 2020 among: (1) EULAR scientific member society leaders, (2) EULAR and Emerging EULAR Network (EMEUNET) members and (3) EULAR Council members. Statistics were descriptive with significance testing for male/female responses assessed by χ Data from EULAR scientific member societies in 13 countries indicated that there were disproportionately fewer women in academic rheumatology than in clinical rheumatology, and they tended to be under-represented in senior academic roles. From 324 responses of EULAR and EMEUNET members (24 countries), we detected no gender differences in leadership aspirations, self-efficacy in career advancement and work-life integration as well as the share of time spent on research, but there were gender differences in working hours and the levels of perceived gender discrimination and sexual harassment. There were gender differences in the ranking of 7 of 26 factors impacting career advancement and of 8 of 24 potential interventions to aid career advancement. There are gender differences in career advancement in academic rheumatology. The study informs a EULAR task force developing a framework of potential interventions to accelerate gender-equitable career advancement in academic rheumatology.

Identifiants

pubmed: 35940824
pii: rmdopen-2022-002518
doi: 10.1136/rmdopen-2022-002518
pmc: PMC9367178
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Department of Health
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Nat Hum Behav. 2017 Nov;1(11):791-796
pubmed: 31024130
RMD Open. 2018 Dec 05;4(2):e000780
pubmed: 30714579
Lancet. 2016 Dec 10;388(10062):2948-2958
pubmed: 27105721
Acad Med. 1992 Jan;67(1):59-62
pubmed: 1729997
Arthritis Rheumatol. 2021 Jan;73(1):168-172
pubmed: 33460296
Arthritis Rheum. 2005 Mar;52(3):697-706
pubmed: 15751096
Am J Surg. 2013 Aug;206(2):263-8
pubmed: 23414631
Health Res Policy Syst. 2016 Jul 19;14(1):50
pubmed: 27432056
Health Res Policy Syst. 2017 Feb 21;15(1):12
pubmed: 28222735
J Womens Health (Larchmt). 2018 Mar;27(3):324-332
pubmed: 29048981
Joint Bone Spine. 2019 Nov;86(6):669-672
pubmed: 31220622
Gastroenterology. 1997 Aug;113(2):669-74
pubmed: 9247490
Lancet. 2019 Feb 9;393(10171):550-559
pubmed: 30739690
Ann Rheum Dis. 2020 Aug 4;:
pubmed: 32753419
J Womens Health (Larchmt). 2008 Sep;17(7):1111-8
pubmed: 18657042
BMJ Open. 2020 Mar 25;10(3):e033480
pubmed: 32213518
JAMA Intern Med. 2016 Sep 1;176(9):1294-304
pubmed: 27400435
JAMA. 2016 May 17;315(19):2120-1
pubmed: 27187307
Hum Resour Health. 2017 Jan 6;15(1):2
pubmed: 28061790
Eval Health Prof. 2007 Dec;30(4):303-21
pubmed: 17986667
Acad Med. 2001 May;76(5):453-65
pubmed: 11346523
Z Rheumatol. 2021 Sep 17;:
pubmed: 34535820
Acad Med. 2012 Jul;87(7):859-69
pubmed: 22622213
BMJ. 2020 Oct 26;371:m3975
pubmed: 33106283
Ann Intern Med. 2018 Nov 6;169(9):654-655
pubmed: 30083757
Ann Intern Med. 2000 Jun 6;132(11):889-96
pubmed: 10836916
Ann Rheum Dis. 2020 May 13;:
pubmed: 32404339
Ann Rheum Dis. 2020 Aug;79(8):1122-1123
pubmed: 32102797
Arthritis Rheumatol. 2021 Jan;73(1):162-167
pubmed: 32812398
West J Med. 1991 Apr;154(4):423-6
pubmed: 1877183
J Gen Intern Med. 2013 Feb;28(2):201-7
pubmed: 22936291
EClinicalMedicine. 2020 Mar 04;20:100298
pubmed: 32300744
Reumatismo. 2020 Jan 28;71(4):173-176
pubmed: 31995955
BMJ. 2015 Dec 16;351:h6311
pubmed: 26673637
Lancet. 2019 Feb 9;393(10171):493
pubmed: 30739666
RMD Open. 2022 Mar;8(1):
pubmed: 35246471
Nat Rev Rheumatol. 2020 Dec;16(12):669-670
pubmed: 32989312
RMD Open. 2020 Feb;6(1):
pubmed: 32584783
Nat Hum Behav. 2018 Oct;2(10):726-734
pubmed: 31406295

Auteurs

Pavel V Ovseiko (PV)

Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Laure Gossec (L)

Institut Pierre Louis d'Epidémiologie et de Santé Publique, INSERM, Sorbonne Universite, Paris, France.
Rheumatology Department, APHP.Sorbonne Universite, Hopital Universitaire Pitie Salpetriere, Paris, France.

Laura Andreoli (L)

Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Unit of Rheumatology and Clinical Immunology, ASST Spedali Civili di Brescia, Brescia, Italy.

Uta Kiltz (U)

Department of Rheumatology, Rheumazentrum Ruhrgebiet, Ruhr-University Bochum, Herne, Germany.

Leonieke van Mens (L)

Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands.

Neelam Hassan (N)

Department of Rheumatology, Southmead Hospital, North Bristol NHS Trust, Bristol, UK.
Musculoskeletal Research Unit, University of Bristol, Bristol, UK.

Marike van der Leeden (M)

Department of Rehabilitation Medicine, Amsterdam Movement Sciences, Reade Centre for Rehabilitation and Rheumatology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.

Heidi J Siddle (HJ)

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
NIHR Leeds Musculoskeletal Biomedical Research Centre, Leeds, UK.

Alessia Alunno (A)

Internal Medicine and Nephrology Unit, Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.

Iain B McInnes (IB)

Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK.

Nemanja S Damjanov (NS)

University of Belgrade School of Medicine, Medigroup Hospital, Rheumatology, Belgrade, Serbia.

Florence Apparailly (F)

IRMB, University of Montpellier, INSERM, Montpellier, France.

Caroline Ospelt (C)

Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland.
University of Zurich, Zurich, Switzerland.

Irene E van der Horst-Bruinsma (IE)

Department of Rheumatology, Amsterdam University Medical Center, Location VU Medical Center, Amsterdam, The Netherlands.

Elena Nikiphorou (E)

Rheumatology Department, King's College Hospital, London, UK.
Centre for Rheumatic Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.

Katie L Druce (KL)

Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Sciences, The University of Manchester, Manchester, UK.

Zoltán Szekanecz (Z)

Department of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

Alexandre Sepriano (A)

Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
NOVA Medical School, Universidade Nova de Lisboa, Lisbon, Portugal.

Tadej Avcin (T)

Department of Allergology, Rheumatology and Clinical Immunology, University Children's Hospital, University Medical Center Ljubljana, Ljubljana, Slovenia.

George Bertsias (G)

Department of Rheumatology, Clinical Immunology and Allergy, University of Crete Medical School, Heraklion, Greece.

Georg Schett (G)

Deutsches Zentrum für Immuntherapie, Friedrich-Alexander-University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany.
Department of Internal Medicine 3, Friedrich-Alexander-University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Anne-Maree Keenan (AM)

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
School of Healthcare, University of Leeds, Leeds, UK.
NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK.

Linda H Pololi (LH)

National Initiative on Gender, Culture and Leadership in Medicine: C-Change, Women's Studies Research Center, Brandeis University, Waltham, Massachusetts, USA.

Laura C Coates (LC)

NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK laura.coates@ndorms.ox.ac.uk.
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH